CORT
Corcept TherapeuticsBNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
+
Peers tracked
11
U.S. public peers
Grade Position
In line
vs peer average
CORT vs peer average
60/100
CORT vs. peer average (B vs. C)
Grade spread
A 2 · B 2 · C 5 · D 2
Graded peers loaded
Coverage
11 graded
100% of tracked
Peer overview
AMGN is the first available peer comparator.
Amgen is a large-cap adjacent biopharma comparator, not a direct indication peer. It provides context for oncology commercialization discipline and lifecycle management, while highlighting that Corcept still carries materially higher single-asset and development concentration risk.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
CORT
Corcept Therapeutics
AMGN
Amgen
Grade
B
C
Momentum
94
36
Value
59
64
Sentiment
17
47
Setup Bias
Net Bullish
-
Market Cap
-
-
Posture
Constructive
Mixed
Grade position vs AMGN
CORT / AMGN
Grade Position
In line
CORT vs. peer average (B vs. C)
60/100
Momentum
94
CORTValue
59
AMGNSentiment
17
AMGNRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs CORT
AMGN is the first peer returned for this comparison set.